Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial to Compare the Efficiency and Side Effect Between Olanzapine and Long-acting Paliperidone Palmitate Injection in Schizophrenia

NCT02918825 is registered in ClinicalTrials.gov with Beijing HuiLongGuan Hospital as lead sponsor.

NCT NCT02918825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02918825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial to Compare the Efficiency and Side Effect Between Olanzapine and Long-acting Paliperidone Palmitate Injection in Schizophrenia
Lead sponsor
Beijing HuiLongGuan Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2016
Completion date
September 30, 2017
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia